Alcami Corp:企業の戦略的SWOT分析

GlobalDataが発行した調査報告書(GDPH1000046SA)
◆英語タイトル:Alcami Corp - Strategic SWOT Analysis Review
◆商品コード:GDPH1000046SA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年1月24日
◆ページ数:30
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Alcami Corp – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Alcami Corp (Alcami), formerly AAIPharma Services Corp/Cambridge Major Laboratories, Inc (AAI/CML) is contract development and manufacturing company (CDMO) that offers a comprehensive range of pharmaceutical development and manufacturing services to services to pharmaceutical, biotechnology and medical device companies across the world. Its key services include active pharmaceutical ingredients (API) development and manufacturing, solid state chemistry development, formulation development, stability services, and analytical development and testing services. The company also provides infrastructure and clinical data management services and packaging components development services and operates through a network of facilities in Europe and the US. Alcami is headquartered in Wilmington, North Carolina, the US.

Alcami Corp Key Recent Developments

Nov 07, 2016: Dr. Stephan Kutzer, Alcami CEO & President, Appointed to DCAT Board of Directors
Oct 22, 2016: Alcami Announces Enhanced Analytical Services in Edison, New Jersey
Sep 08, 2016: Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities
Aug 11, 2016: Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI
Jun 20, 2016: Alcami Announces Enhanced Laboratory Services in Wilmington, NC Headquarters

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 – About the Company 5
Alcami Corp – Key Facts 5
Alcami Corp – Key Employees 6
Alcami Corp – Major Products and Services 7
Alcami Corp – History 8
Alcami Corp – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Alcami Corp – Business Description 11
Alcami Corp – SWOT Analysis 12
SWOT Analysis – Overview 12
Alcami Corp – Strengths 12
Alcami Corp – Weaknesses 13
Alcami Corp – Opportunities 14
Alcami Corp – Threats 15
Alcami Corp – Key Competitors 16
Section 3 – Company’s Lifesciences Financial Deals and Alliances 17
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 17
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 18
Alcami Corp, Recent Deals Summary 19
Section 4 – Company’s Recent Developments 20
Nov 07, 2016: Dr. Stephan Kutzer, Alcami CEO & President, Appointed to DCAT Board of Directors 20
Oct 22, 2016: Alcami Announces Enhanced Analytical Services in Edison, New Jersey 21
Sep 08, 2016: Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities 22
Aug 11, 2016: Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI 23
Jun 20, 2016: Alcami Announces Enhanced Laboratory Services in Wilmington, NC Headquarters 24
May 12, 2016: Alcami Invests in MicroSEQ Rapid Microbial Identification System to Expand its Service Capabilities at Four U.S. Sites 25
Mar 16, 2016: AAI Pharma Services And Cambridge Major Laboratories Are Now Alcami 26
Feb 17, 2016: Investment of $10.7M in New Facility at Cortex Innovation Center in St. Louis, MO 27
Feb 17, 2016: AAIPharma / Cambridge Major Laboratories to Invest $10.7M in New Facility at Cortex Innovation Center in St. Louis, MO 28
Feb 11, 2016: AAIPharma Services Corp. / Cambridge Major Laboratories Announces Expanded Capabilities and Capacity for Sterile Drug Product Manufacturing in Charleston, SC 29
Section 5 – Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Alcami Corp, Key Facts 5
Alcami Corp, Key Employees 6
Alcami Corp, Major Products and Services 7
Alcami Corp, History 8
Alcami Corp, Other Locations 10
Alcami Corp, Key Competitors 16
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 17
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 18
Alcami Corp, Recent Deals Summary 19

List of Figures
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 17
Alcami Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 18

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Alcami Corp:企業の戦略的SWOT分析(Alcami Corp - Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆